These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 24471407
1. Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide. Paragomi P, Rahimian R, Kazemi MH, Gharedaghi MH, Khalifeh-Soltani A, Azary S, Javidan AN, Moradi K, Sakuma S, Dehpour AR. Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):118-26. PubMed ID: 24471407 [Abstract] [Full Text] [Related]
2. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway. Shamshiri H, Paragomi P, Paydar MJ, Moezi L, Bahadori M, Behfar B, Ardalan FA, Dehpour AR. J Gastroenterol Hepatol; 2009 Apr; 24(4):672-80. PubMed ID: 19032458 [Abstract] [Full Text] [Related]
3. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models. Xu JR, Luo JY, Shang L, Kong WM. Chin J Dig Dis; 2006 Apr; 7(2):89-96. PubMed ID: 16643336 [Abstract] [Full Text] [Related]
4. Possible involvement of PPAR-gamma receptor and nitric oxide pathway in the anticonvulsant effect of acute pioglitazone on pentylenetetrazole-induced seizures in mice. Adabi Mohazab R, Javadi-Paydar M, Delfan B, Dehpour AR. Epilepsy Res; 2012 Aug; 101(1-2):28-35. PubMed ID: 22436324 [Abstract] [Full Text] [Related]
5. Effect of nitrergic system on colonic motility in a rat model of irritable bowel syndrome. Temiz TK, Demir O, Simsek F, Kaplan YC, Bahceci S, Karadas B, Celik A, Koyluoglu G. Indian J Pharmacol; 2016 Aug; 48(4):424-429. PubMed ID: 27756955 [Abstract] [Full Text] [Related]
6. Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome. Zielińska M, Chen C, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Sałaga M, Małecka-Panas E, Wlaź P, Krajewska WM, Fichna J. J Pharm Pharmacol; 2015 Feb; 67(2):244-54. PubMed ID: 25515402 [Abstract] [Full Text] [Related]
7. Anti-pruritic activity of pioglitazone on serotonin-induced scratching in mice: possible involvement of PPAR-gamma receptor and nitric oxide. Shafizadeh M, Rajaba A, Imran khan M, Ostadhadi S, Rastegar H, Dehpour A. Eur J Pharmacol; 2014 Dec 05; 744():103-7. PubMed ID: 25310911 [Abstract] [Full Text] [Related]
8. Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway. Sadaghiani MS, Javadi-Paydar M, Gharedaghi MH, Fard YY, Dehpour AR. Behav Brain Res; 2011 Oct 31; 224(2):336-43. PubMed ID: 21704657 [Abstract] [Full Text] [Related]
9. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome. Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW. Aliment Pharmacol Ther; 2008 Jan 15; 27(2):197-206. PubMed ID: 17973974 [Abstract] [Full Text] [Related]
10. Pharmacological evidence for systemic and peripheral antinociceptive activities of pioglitazone in the rat formalin test: Role of PPARγ and nitric oxide. Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Rajabi H, Pashmforoush M. Eur J Pharmacol; 2017 Jun 15; 805():84-92. PubMed ID: 28286124 [Abstract] [Full Text] [Related]
11. Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome. Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. J Pharmacol Sci; 2019 Jan 15; 139(1):46-49. PubMed ID: 30522964 [Abstract] [Full Text] [Related]
12. The effects of sildenafil on rectal sensitivity and tone in patients with the irritable bowel syndrome. Gonçalves de Medeiros MT, de Oliveira RB, dos Santos AA, de Leopoldino DM, Lima MC, Nobre RA, Nobre e Souza MÂ. Aliment Pharmacol Ther; 2012 Mar 15; 35(5):577-86. PubMed ID: 22229478 [Abstract] [Full Text] [Related]
13. Antidepressant-like effect of atorvastatin in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway. Shahsavarian A, Javadi S, Jahanabadi S, Khoshnoodi M, Shamsaee J, Shafaroodi H, Mehr SE, Dehpour A. Eur J Pharmacol; 2014 Dec 15; 745():52-8. PubMed ID: 25446923 [Abstract] [Full Text] [Related]
14. [Altered expression of L-type calcium channel alpha1C and alpha1D subunits in colon of rats with diarrhea-predominant irritable bowel syndrome]. Zhu J, Luo HS, Chen L, Zhou T. Zhonghua Yi Xue Za Zhi; 2009 Oct 20; 89(38):2713-7. PubMed ID: 20137275 [Abstract] [Full Text] [Related]
15. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study. Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS. Gastroenterology; 2013 Aug 20; 145(2):329-38.e1. PubMed ID: 23583433 [Abstract] [Full Text] [Related]
16. Expression of inducible nitric oxide synthase in mast cells contributes to the regulation of inflammatory cytokines in irritable bowel syndrome with diarrhea. An S, Zong G, Wang Z, Shi J, Du H, Hu J. Neurogastroenterol Motil; 2016 Jul 20; 28(7):1083-93. PubMed ID: 26940641 [Abstract] [Full Text] [Related]
17. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats. Majithiya JB, Paramar AN, Balaraman R. Cardiovasc Res; 2005 Apr 01; 66(1):150-61. PubMed ID: 15769458 [Abstract] [Full Text] [Related]
18. Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems. Mao Y, Li Z, Chen K, Yu H, Zhang S, Jiang M, Ma Y, Liang C, Liu H, Li H, Hua Q, Zhou H, Sun Y, Fan X. Cell Physiol Biochem; 2017 Apr 01; 43(2):518-530. PubMed ID: 28930716 [Abstract] [Full Text] [Related]
19. Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice. Allami N, Javadi-Paydar M, Rayatnia F, Sehhat K, Rahimian R, Norouzi A, Dehpour AR. Eur J Pharmacol; 2011 Jan 10; 650(1):240-8. PubMed ID: 20951129 [Abstract] [Full Text] [Related]
20. Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome. Zielińska M, Jarmuż A, Wasilewski A, Cami-Kobeci G, Husbands S, Fichna J. Pharmacol Rep; 2017 Apr 10; 69(2):350-357. PubMed ID: 28187396 [Abstract] [Full Text] [Related] Page: [Next] [New Search]